Pharmacyclics LLC - Company Profile
Powered by 
All the sales intelligence you need on Pharmacyclics LLC in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Pharmacyclics LLC fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Pharmacyclics LLC.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Pharmacyclics LLC (Pharmacyclics), a subsidiary of Abbvie, is a biopharmaceutical company that discovers, develops and commercializes novel small-molecule drugs for the treatment of cancer and immunological disorders. Pharmacyclics has one marketed product, Imbruvica (ibrutinib) is a once-daily, first-in-class Bruton’s tyrosine kinase (BTK) inhibitor targeting anti-inflammatory and autoimmune indications. It is approved for use in various indications in the US and is the only product to have received four breakthrough therapy designations by the US FDA.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer